Animal Vaccine Market Size, Share, Regional Outlook, Industry Analysis, Forecast 2024-2032

Written by Mark Smith  »  Updated on: May 22nd, 2024

Animal Vaccine Market Size, Share, Regional Outlook, Industry Analysis, Forecast 2024-2032

The latest report by IMARC Group, titled ‘Animal Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,' offers a comprehensive analysis of the animal vaccine market outlook. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

The global animal vaccine market size reached US$ 13.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.24% during 2024-2032.

An animal vaccine is a biological preparation that stimulates an animal's immune system to develop immunity against specific pathogens, thereby preventing disease. These vaccines are essential tools in veterinary medicine, used across various species, including pets, livestock, and wildlife. Their primary use is to prevent the morbidity and mortality associated with infectious diseases, which can lead to significant economic losses, particularly in the livestock industry, and potential zoonotic transmissions to humans. They protect animal health, increase livestock productivity, and reduce the need for antibiotics, thus minimizing the risk of antibiotic resistance. There are several types of animal vaccines, including live attenuated vaccines, inactivated vaccines, and subunit vaccines.  Each type is tailored to elicit a robust immune response specific to the pathogens that threaten animal health.  

Request to Get the Sample Report:

Market Trends:

The rising incidence of zoonotic diseases, which are infectious diseases that can be transmitted between animals and humans, is driving the global market. With the growing demand for meat, dairy, and other animal products, the need to ensure the health and productivity of livestock has become paramount, leading to greater adoption of vaccines. Additionally, the companion animal segment is seeing increased vaccination rates due to the rising trend of pet ownership and the growing awareness of pet health.

Furthermore, continual technological advancements in vaccine development are another crucial driver. Emerging innovations such as recombinant DNA vaccines, live attenuated vaccines, and nanoparticle-based vaccines are improving the efficacy, safety, and delivery of animal vaccines. These advancements are making vaccines more accessible and effective, thereby propelling their adoption. Moreover, regulatory support and government initiatives to control and eradicate animal diseases are playing a vital role in market growth. Governments across various countries are implementing vaccination programs and providing subsidies to encourage farmers and pet owners to vaccinate their animals.        

Explore Full Report with Table of Contents:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • H. Boehringer Sohn AG & Co. KG
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated (Eli Lilly and Company)
  • Hester Biosciences Limited
  • Hipra S.A.
  • Hygieia Biological Laboratories
  • Merck & Co. Inc.
  • Phibro Animal Health Corporation
  • Vaxxinova GmbH (EW Group)
  • Virbae
  • Zoetis Services LLC

Animal Vaccine Market Segmentation:

Our report has categorized the market based on region, product, animal type, route of administration.

Breakup by Product:

  • Attenuated vaccines
  • Inactivated vaccines
  • Subunit vaccines
  • Toxoid vaccines
  • Conjugate vaccines
  • Recombinant vaccines
  • DNA vaccines Type

Breakup by Animal Type:

  • Companion animal  

    • Dogs
    • Cats

  • Livestock animal  

    • Cattle
    • Pigs
    • Poultry
    • Sheep
    • Others

  • Aquaculture

Breakup by Route of Administration:

  • Subcutaneous
  • Intramuscular
  • Intranasal
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2018-2023)
  • Market Outlook (2024-2032)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

Related Posts